Firstpost
  • Home
  • Video Shows
    Vantage Firstpost America Firstpost Africa First Sports
  • World
    US News
  • Explainers
  • News
    India Opinion Cricket Tech Entertainment Sports Health Photostories
  • Asia Cup 2025
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
Trending:
  • PM Modi in Manipur
  • Charlie Kirk killer
  • Sushila Karki
  • IND vs PAK
  • India-US ties
  • New human organ
  • Downton Abbey: The Grand Finale Movie Review
fp-logo
GSK gets Sebi nod for open offer to Indian subsidiary
Whatsapp Facebook Twitter
Whatsapp Facebook Twitter
Apple Incorporated Modi ji Justin Trudeau Trending

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit
  • Home
  • Fwire
  • GSK gets Sebi nod for open offer to Indian subsidiary

GSK gets Sebi nod for open offer to Indian subsidiary

FP Archives • December 20, 2014, 20:54:47 IST
Whatsapp Facebook Twitter

UK-based GlaxoSmithKline (GSK) has received market regulator Sebi’s approval for its over Rs 5,200 crore open offer for Indian subsidiary GlaxoSmithKline Consumer Healthcare.

Advertisement
Subscribe Join Us
Add as a preferred source on Google
Prefer
Firstpost
On
Google
GSK gets Sebi nod for open offer to Indian subsidiary

Mumbai: UK-based GlaxoSmithKline (GSK) has received market regulator Sebi’s approval for its over Rs 5,200 crore open offer for Indian subsidiary GlaxoSmithKline Consumer Healthcare.

The British pharma and consumer products maker had filed its draft offer document with Sebi (Securities and Exchange Board of India) on December 11 to acquire 31.8 percent stake in its Indian subsidiary for more than Rs 5,200 crore.

[caption id=“attachment_582323” align=“alignleft” width=“400”] ![](https://images.firstpost.com/wp-content/uploads/2013/01/gsk1_reuters.jpg "gsk1_reuters") Sebi issued its final observations on the draft offer documents on January 4 as per the latest update by the market regulator. Reuters[/caption]

STORY CONTINUES BELOW THIS AD

Sebi issued its final observations on the draft offer documents on January 4 as per the latest update by the market regulator. Sebi’s observations are necessary for the companies to launch open offers. The offer is scheduled to open from January 17, according to the announcement made by HSBC on behalf of GSK and is expected to close on January 30.

More from Fwire
BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents BCCI earned more than Rs 2,400 crore in IPL 2022, reveal documents Eight Russian judokas barred from world championships after Ukraine boycott Eight Russian judokas barred from world championships after Ukraine boycott

The UK parent had made an offer to acquire up to 13,389,410 shares, representing 31.8 percent of the total outstanding shares of the GlaxoSmithKline Consumer Healthcare. The company would buy the shares at Rs 3,900 apiece taking the potential total value of the transaction to around Rs 5,220 crore.

Shares of the Indian company were trading at Rs 3,868.40 apiece in afternoon trade on the BSE. In November, GlaxoSmithKline had offered to hike stake in its GlaxoSmithKline Consumer Healthcare to up to 75 percent. As on quarter ended September 2012, the foreign promoter of GlaxoSmithKline Consumer Healthcare held 43.2 percent stake in the company while the public shareholding was at 56.84 percent.

PTI

Tags
SEBI CompanyWatch Open offer Glaxo SmithKline
End of Article
Written by FP Archives

see more

Latest News
Find us on YouTube
Subscribe
End of Article

Top Stories

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

Russian drones over Poland: Trump’s tepid reaction a wake-up call for Nato?

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

As Russia pushes east, Ukraine faces mounting pressure to defend its heartland

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Why Mossad was not on board with Israel’s strike on Hamas in Qatar

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Turkey: Erdogan's police arrest opposition mayor Hasan Mutlu, dozens officials in corruption probe

Top Shows

Vantage Firstpost America Firstpost Africa First Sports
Latest News About Firstpost
Most Searched Categories
  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025
NETWORK18 SITES
  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
Firstpost Logo

is on YouTube

Subscribe Now

Copyright @ 2024. Firstpost - All Rights Reserved

About Us Contact Us Privacy Policy Cookie Policy Terms Of Use
Home Video Shorts Live TV